Aeovian is a California-based biopharmaceutical company that researches and develops small-molecule therapies to treat genetic and age-related diseases.
$50M
Mar 28, 2024
-
Tubulis is a Germany-based biotechnology company that develops antibody-drug conjugates for the treatment of cancer and infectious diseases.
$138.8M
Mar 13, 2024
-
Carrick Therapeutics is an Ireland-based biopharmaceutical company that researches and develops novel therapies for the treatment of cancer.
$25M
Nov 30, 2022
-
Cajal Neuroscience is a Washington-based biotechnology company that develops and commercializes novel therapeutics for the treatment of neurodegenerative diseases.
$96M
Nov 28, 2022
-
Tubulis is a Germany-based biotechnology company that develops antibody-drug conjugates for the treatment of cancer and infectious diseases.
$63M
May 02, 2022
-
Frequently Asked Questions about Evotec
What is Evotec investing in?
Evotec has invested in 27 companies including Aeovian, Tubulis and Carrick Therapeutics
What company did Evotec invest in?
Evotec invested in a total 27 companies including Aeovian, Tubulis and Carrick Therapeutics
What are the top 5 investments by Evotec?
The top companies in which Evotec invested are Aeovian, Tubulis, Carrick Therapeutics, Cajal Neuroscience and Tubulis
